In the afternoon of August 28, 2017, Dr. Ming-Wei Wang (Director, the National Center for Drug Screening/Chinese National Compound Library and Dean, School of Pharmacy, Fudan University) met with Dr. Katie Jing Su, Head of Operation of GlaxoSmithKline (GSK, U.K.) China R&D Center at the Chinese National Compound Library. They discussed possible ways to carry out bilateral collaboration under the new situation. Dr. Su once served as Vice President of Novo Nordisk China R&D Center where she established more than 10 year’s friendly relationship with the National Center for Drug Screening led by Professor Wang.